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A novel filarial serine protease inhibitor (SPI) from the human
parasitic nematode Onchocerca volvulus, Ov-SPI-1, was identified
through the analysis of a molting third-stage larvae expressed
sequence tag dataset. Subsequent analysis of the expressed
sequence tag datasets of O. volvulus and other filariae identified
four other members of this family. These proteins are related to the
low molecular weight SPIs originally isolated from Ascaris suum
where they are believed to protect the parasite from host intestinal
proteases. The twoOv-spi transcripts are up-regulated in the molt-
ing larvae and adult stages of the development of the parasite.
Recombinant Ov-SPI-1 is an active inhibitor of serine proteases,
specifically elastase, chymotrypsin, and cathepsin G. Immunolocal-
ization of the Ov-SPI proteins demonstrates that the endogenous
proteins are localized to the basal layer of the cuticle of third-stage,
molting third-stage, and fourth-stage larvae, the body channels and
multivesicular bodies of third-stage larvae and the processed mate-
rial found between the two cuticles during molting. In O. volvulus
adult worms the Ov-SPI proteins are localized to the sperm and to
eggshells surrounding the developing embryos. RNA interference
targeting theOv-spi genes resulted in the specific knockdown of the
transcript levels of bothOv-spi-1 andOv-spi-2, a loss of native pro-
teins, and a significant reduction in both molting and viability of
third-stage larvae. We suggest the Ov-SPI proteins play a vital role
in nematode molting by controlling the activity of an endogenous
serine protease(s). The localization data in adults also indicate that
these inhibitors may be involved in other processes such as embry-
ogenesis and spermatogenesis.
The cuticle is an extracellular hydroskeleton that overlays the hypo-
dermis of all nematodes. Most nematodes molt their cuticles four times
during pre-adult development. Although being fairly inert and structur-
ally robust, the cuticle is also permeable to small compounds and
expands during growth periods between molts (1). A number of
enzymes have been implicated in the shedding of old cuticles and the
remodeling process that occurs as the new cuticle develops (2–8). Pro-
teolytic enzymes have been shown to play a vital role in these processes,
and inhibitor studies and rational cloning strategies have identified sev-
eral nematode proteases whose functions are required for molting
(9–11).
To identify novel filarial proteins involved in the molting process, we
adopted a transcriptomics approach. Thousands of expressed sequence
tags (ESTs)4 have been sequenced from cDNA libraries constructed
from the infective third-stage larvae (L3) and molting L3 (mL3) of the
human filarial nematodeOnchocerca volvulus (12, 13). Analysis of these
datasets identified novel cysteine proteases involved in the molting
process (14, 15). Also identified in these analyses was an O. volvulus
small molecular weight serine protease inhibitor (SPI) with similarities
to other nematode SPI; Ascaris suum chymotrypsin/elastase inhibitors
and hookworm factors VII and Xa inhibitors (12, 16, 17).
Protease inhibitors play a variety of important biological roles by
controlling endogenous and exogenous proteolytic activities. In para-
sitic nematodes they have been implicated in the parasite’s survival
within the host by inhibition of exogenous host proteases normally
found in their preferred microenvironments (18–22), the inhibition of
enzymes found in plasma or secreted from immune effector cells (17,
23–25), and the modulation of immune responses (26–29). Their
endogenous roles have been less studied. It has been postulated that
proteases involved in the molting process would be controlled by mat-
uration (through removal of inhibitory pro-regions) or via endogenous
protease inhibitors. In O. volvulus a cystatin-like cysteine protease
inhibitor, onchocystatin or Ov-CPI-2, has been identified, which local-
ized to the cuticle ofmolting nematodes and developing embryos (30). It
has been suggested that it might play a role in modulating the activity of
cysteine proteases required for the L3 to fourth-stage larvae (L4)molt or
eggshell morphogenesis in embryos. We now present data indicating
that the SPI identified in the molting EST dataset belongs to a family of
proteins that play vital roles in the O. volvulus L3 to L4 molt and are
* The costs of publication of this article were defrayed in part by the payment of page
charges. This articlemust therefore be herebymarked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI
Data Bankwith accession number(s) DQ013154, DQ013161, DQ011671, andDQ011672.
1 Both authors contributed equally to this work.
2 Funded by the Wellcome Trust. Work in Edinburgh was funded by the UK Medical
Research Council. Initial work at Smith College byD. B. G. was funded by aHampshire
College Division III Howard HughesMedical Institute Award and the EdnaMcConnell
Clarke Foundation.
3 Towhom correspondence should be addressed: Laboratory of Molecular Parasitology,
Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th St., New
York, NY 10021. Tel.: 212-570-3119; Fax: 212-570-3121; E-mail: slustigman@
nybloodcenter.org.
4 The abbreviations used are: EST, expressed sequence tag; L2, second-stage larvae; L3,
third-stage larvae;mL3,molting third-stage larvae; L4, fourth-stage larvae; Mf, micro-
filariae; AM, adult male; AF, adult female; Ov, O. volvulus; Bm, B. malayi; Di, D. immitis;
Ls, L. sigmodontis; SPI, serine protease inhibitor; TIL, trypsin inhibitor-like; IC/E, inhib-
itor of chymotrypsin/elastase; BLAST, basic local alignment search tool; RNAi, RNA
interference; dsRNA, double-stranded RNA; AMC, 7-amino-4-methylcoumarin; Suc,
succinyl; Z, benzyloxycarbonyl; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetra-
zolium bromide; aa, amino acid(s).
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 280, NO. 49, pp. 40845–40856, December 9, 2005
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
DECEMBER 9, 2005•VOLUME 280•NUMBER 49 JOURNAL OF BIOLOGICAL CHEMISTRY 40845
 by guest on June 13, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
suggested to be involved in other processes such as embryogenesis and
spermatogenesis.
EXPERIMENTAL PROCEDURES
Identification and Cloning of the Filarial Serine Protease Inhibitor
Genes, Ov-spi-1, Ov-spi-2, Bm-spi-1, Di-spi-1, and Ls-spi-1—Analysis of
ESTs from an O. volvulus mL3 cDNA expression library (SL96MLW-
OvmL3) identified a potential serine protease inhibitor (Ov-spi-1,
O. volvulus clusters OVC00017 and OVC03875), which is highly
expressed in the mL3 (12). Subsequent BLAST (31) searches of the O.
volvulus EST dataset revealed a second closely related sequence, which
has been designated Ov-spi-2. BLAST searches of other filarial EST
datasets identified further members of this gene family in Brugia malayi,
Dirofilaria immitis, and Litomosoides sigmodontis. Representative EST
clones forOv-spi-1 (cDNA clone SWOv3MCA025SK, GenBankTM acces-
sion AA294761), Ov-spi-2 (SWOv3MCA738SK, AA294327), Bm-spi-1
(kb65g12.y1, CB338347; and SWYACAL06G12SK, AW874776), Di-spi-1
(ke26b11.y1, BQ456080), and Ls-spi-1 (Ls_AM1_09G07_T7, CD203523)
were obtained from the Blaxter laboratory (University of Edinburgh, Edin-
burgh, UK), the Filarial Genome Project Network repository (Smith Col-
lege, Northampton,MA), or the Genome Sequencing CenterWashington
University (St. Louis, MO). The plasmid inserts were fully sequenced on
both strands using both vector-specific and gene-specific primers. The
confirmed EST sequences have been deposited in GenBankTM (Ov-spi-1,
DQ011671; Ov-spi-2, DQ011672; Bm-spi-1, DQ013154; Di-spi-1,
DQ013156; and Ls-spi-1, DQ013157).
The genomic sequences of the filarial spi genes were obtained by PCR
amplification from total genomic DNA from each species using Long
Range Taq (Stratagene, La Jolla, CA) and gene-specific primers (Bm-
spi-1.F2: 5-CACATTTGTAAACTGCTGAGAAG-3; Bm-spi-1.R2:
5-CTAAAACTTTTATCGACTGAATAC-3; Ls-spi-1.F1: 5-ATCA-
GAAATTACAAAGAGAATAG-3; Ls-spi-1.R1: 5-ATTGAACTCT-
CACATTTCGATGA-3; Di-spi-1.F1: 5-TATAAAACAATGAAAA-
GTAAG-3; and Di-spi-1.R1: 5-GCATATTTTATCTACCGTTTGG-
G-3). PCR fragments were gel-purified (Qiagen kit, Qiagen Inc.,
Valencia, CA) and cloned into pCR4-TOPO vector (Invitrogen). For
each fragment clones were selected and fully sequenced using vector-
and gene-specific primers.
Sequence and Phylogenetic Analysis of the Filarial SPI Sequences—
The five filarial SPI peptide sequences were compared with each other
and the public datasets (NCBI GenBankTM, pFam, SMART) using
BLAST and ClustalX (www.sanger.ac.uk/Software/Pfam/and smart-
.embl-heidelberg.de/) (31–34). The inhibitory domain identified within
the filarial SPIs has been designated TIL (trypsin inhibitor-like) within
PFAM (PF01826). The previously identified members isolated from A.
suum have been assigned toMEROPS proteinase inhibitor family I8 and
I40, clan IA and I- (35). For the purpose of this study we limited our
analysis to the nematodeTIL domain containing proteins found inGen-
BankTM and did not include any additional nematode TILs found in the
non-filarial nematode EST datasets. The sequences included in this
study include the four filarial SPI sequences (ONCVU_SPI_1, BRU-
MA_SPI_1, DIRIM_SPI_1, LITSI_SPI_1), eleven predicted Caenorhab-
ditis elegans proteins (36) containing a single TIL domain (CAEEL_C-
25E10_10, AAA92315; CAEEL_C10G8_4, AAB09171; CAEEL_C53B-
7_2, AAC48275; CAEEL_F32D8_3, T21654; CAEEL_F36H9_4, AAO-
12440; CAEEL_K05F1_10, AAA68717; CAEEL_K07A1_6, CAB03176;
CAEEL_R10H1_4, AAM97992; CAEEL_T01D3_6 T21772; CAEEL_T-
06E6_10, CAB03319; and CAEEL_Y26D4A_12, CAE17955), three A.
suum sequences (ASCSU_ATI, P19398; ASCSU_IC/E-1, P07851; and
ASCSU_IC/E-2–5, P07852), five Ancylostoma caninum sequences (A-
NCCA_APc2, AAC47080; ANCCA_APc3, AAP57305; ANCCA_APc4,
AAP82926; ANCCA_APc5, AAC47082; ANCCA_APc6, AAC47081),
twoAncylostoma ceylanicum sequences (ANCCE_AP1,AAK81733 and
ANCCE_AP2, AAD51336), three Anisakis simplex sequences (ANISI_
SPI_1,O77416; ANISI_SPI_2,O77417; andANISI_SPI_3,O77418), and
two sequences identified in Trichuris suis (TRISU_TCI, AAF09189 and
TRISU_CEI, AAF09190). The sequences of the thirty selected TIL
inhibitory domains spanning between the first and the tenth cysteine
residues were used to generate a preliminary multiple sequence align-
ment in ClustalX, which was subsequently optimized by hand editing.
This multiple sequence alignment was used to carry out phylogenetic
analyses using distance (neighbor joining) and Bayesianmethods imple-
mented in PAUP 4.0 (37) and MrBayes (38). For distance methods the
significance of the resulting trees assessed by bootstrap analysis (10,000
replicants). The two T. suis sequences were designated as an outgroup
because of their low sequence similarity to the other sequences and their
lack of some of the conserved structural cysteine residues. T. suis is a
member of the Dorylaimida family and only distantly related to the
other (rhabditid) nematodes considered (39).
Homology Modeling of the Filarial Serine Protease Inhibitors—X-ray
crystal structure of the ASCSU_IC/E-1 inhibitor (AsC/E-1; accession
P07851) bound to porcine elastase was retrieved from the Protein Data
Bank (PDB; code 1EAI) (40). Homology models of the filarial SPIs, Ov-
SPI-1, Bm-SPI-1, Di-SPI-1, and Ls-SPI-1, were built based on the x-ray
crystal structure of ASCSU_IC/E-1 using the automated softwareMod-
eler (41) within Quanta 2000 (Accelrys, San Diego, CA) running on a
Silicon Graphics Octane with a dual R12000 processor (sgi, Mountain
View, CA). The “Refine 3” option in Modeler, which uses a conjugated
gradient together with molecular dynamics by a simulated annealing
technique, was used to optimize the models. Five models for each run
were developed, and the model with the lowest Objective Function was
selected. The resulting models were evaluated for their stereochemical
properties by Procheck software (42) at 2.0 Å and by Quanta Protein
Health programs within Quanta2000.
After initial modeling, each modeled inhibitor was superimposed on
the x-ray crystal structure of the AsC/E-1 inhibitor, the latter was then
removed, and the structure of the modeled inhibitor and elastase were
merged. These steps were performed to investigate the interactions of
the critical residues in the inhibitors with the elastase. The Quanta
Protein Health Check revealed few close contacts of themodeled inhib-
itors with elastase, and high energy. Polar hydrogens were added to the
model and optimized by 200 steps of the Steepest Descent method to
remove the close contacts. The protein backbone was kept fixed during
optimization. The structures of modeled inhibitors bound to elastase
showed no further close contacts and low Charmm energies. These
optimized structures were used for further analysis.
Expression and Purification of the Recombinant Ov-SPI-1 (rOv-SPI-1)—
Themature serine protease inhibitor domain ofOv-SPI-1 (aa 15–118) was
cloned in-frame into both the pProEXHTb (BamH1/HindIII sites) and the
pRSET A (BamH1/EcoR1sites) expression vectors (Invitrogen) and
expressed as a fusionwith anN-terminal polyhistidine tag.Overexpression
of the rOv-SPI-1 fusion protein was as previously describedwithmodifica-
tions (12). Briefly, expression was induced from an overnight culture of
BL21 (DE3) pLysS Escherichia coli cells (Sigma) with isopropyl 1-thio--D-
galactopyranoside at a final concentration of 1mM for 3 h at 37 °C. Recom-
binant proteinwas purified by affinity chromatography on a nickel column
(Probond resin, Invitrogen) according to the manufacturer’s instructions
and dialyzed overnight at 4 °C against phosphate-buffered saline.
Enzyme Inhibitory Activity of rOv-SPI-1—The inhibitory activity of
rOv-SPI-1 was tested against a panel of serine proteases. The enzymes
Multiple Roles of Ov-SPI-1 in O. volvulus Development
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(Sigma) and their 7-amino-4-methylcoumarin (AMC) fluorogenic sub-
strates used were bovine pancreatic trypsin and benzyloxycarbonyl-
Gly-Pro-Arg-AMC (Bachem, Torrance, CA, Z-GPR-AMC); bovine
pancreatic chymotrypsin and Suc-Ala-Ala-Pro-Phe-AMC (Calbio-
chem); porcine pancreatic elastase and Suc-Ala-Ala-Ala-AMC
(Bachem); human leukocyte cathepsin G and Suc-Ala-Ala-Pro-Phe-
AMC (Calbiochem). Chemical protease inhibitors (Sigma) were used as
positive controls of enzyme inhibition (phenylmethylsulfonyl fluoride
(5 mM), L-1-tosylamido-2-phenylethyl chloromethyl ketone (100 M),
1-chloro-3-tosylamido-7-amino-2-heptanone (100 M), EDTA (10
mM), and 1-antitrypsin (5 g/ml)). Phosphate-buffered saline diluted
in enzyme assay buffer was used as a negative control. The reaction
buffer was 100mMTris-HCl, at pH 8.0 for elastase, pH 8.0, and contain-
ing 100mMCaCl2 for chymotrypsin, and pH 7.5, and containing 1.6mM
NaCl for trypsin and cathepsin G. The assay conditions used were as
follows: 0.5g of each serine protease in 50l was incubatedwith 100l
of rOv-SPI-1 (1, 2.5, 5, and 10g/ml; 0.1–1g of final amount/well) for
30 min at room temperature in 96-well black clear-bottom plates
(Fisher Scientific) in appropriate buffer. After the preincubation of the
enzyme and inhibitor, 50 l of an appropriate AMC substrate solution
(10M final concentration) was added, and the residual enzyme activity
was measured by reading the fluorescence (excitation 360/40, emission
460/40) over time using the Bio-Tek FL500 fluorometer or the BMG
Fluorostar plus Optima.
Expression Profile of Ov-spi-1 and Ov-spi-2 throughout the O. volvu-
lus Life Cycle—Primers specific forOv-spi-1 (OvSPI1F; 5-ACGTACG-
TGGATGCGGATC-3 andOvSPI1R2; 5-TGTTCCGATAAGTTAC-
CG-3) andOv-spi-2 (OvSPI1F; and OvSPI2R; 5-GGAAACAAAATC-
TCAGCATC-3) were used to amplify fragments from O. volvulus
cDNA libraries. The specificity of the primers forOv-spi-1 andOv-spi-2
was confirmed by PCR using plasmid DNA encoding the full-length
cDNA sequences of Ov-spi-1 or Ov-spi-2. Each set of primers did not
amplify the non-target spi transcript (data not shown). These include
second-stage larvae (L2, SAW98MLW-OvL2), infective third-stage
larvae (L3, SAW94WL-OvL3), molting third-stage larvae (mL3, SL96-
MLW-OvmL3), adult male (AM, SAW98MLW-OvAM), adult female
(AF, SAW98MLW-OvAF), andmicrofilariae (Mf, SAW98MLW-OvM-
f). The cDNA libraries were constructed by the Filarial Genome Project.
PCR with primers specific to O. volvulus -tubulin cDNA (TubF1; 5-
AATATGTGCCACGAGCAGTC-3 andTubR1; 5-CGGATACTCC-
TCACGAATTT-3) was used as a constitutively expressed transcript
qualitative control. The PCR conditions used were 95 °C for 3 min 1
cycle; 94 °C for 30 s, 55 °C for 30 s, 72 °C for 1 min 40 cycles; 72 °C for
10 min.
Polyclonal Sera Production and Immunolocalization of the Ov-SPI
Proteins—Polyclonal sera raised against rOv-SPI-1 was produced in
mice using the immunization protocol previously described (43).
Briefly, 6- to 8-week-old male BALB/cByJ mice were injected subcuta-
neously with 25 g of rOv-SPI-1 in 0.1 ml of phosphate-buffered saline
with 0.1 ml of (Sigma). Mice were boosted 14 days later with 25 g of
rOv-SPI-1 in Freund’s complete adjuvant. Antibody specificity was
screened by Western blot analysis against the rOv-SPI-1 and other
recombinant proteins. It was specific to rOv-SPI-1 only (data not
shown).
Stage-specific O. volvulus worms (L3, mL3, adult female, and adult
male) were isolated as described previously (30, 44). Worms were fixed
for 30 min in 0.25% glutaraldehyde, 1% sucrose in 0.1 M phosphate
buffer, pH 7.4, and then processed for immunoelectron microscopy as
previously described (30, 45). For the immunolocalization of the native
parasite proteins corresponding to Ov-SPI, thin sections (70 nm) of
embedded worms were incubated with antibodies raised against rOv-
SPI-1 (mouse anti-Ov-SPI-1), followed by incubation with rabbit anti-
mouse IgG, and then incubation in a suspension of 15-nm gold particles
coated with protein A (Amersham Biosciences). Pre-immune serum
was used as the control.
Double-stranded RNA Preparation and RNA Interference—RNAi
treatment ofO. volvulusL3was carried out using dsRNAas described by
Lustigman et al. (46). The matureOv-SPI-1 in pProEX HTb expression
vector was used to amplify the cDNA corresponding to the region
encoding mature Ov-SPI-1 (position 67–362), which also corresponds
to bp 67–349 of the cDNA encoding Ov-SPI-2, using primers specific
forOv-spi-1 (OvSPI1F; as above and OvSPI1R; 5-CGAAATTTCATA-
GAGTCTTCCG-3), and the PCR fragment was then subcloned into
pCR4-TOPO vector (Invitrogen) to use as the template for RNA syn-
thesis. The cDNA was amplified with M13 forward and M13 reverse
primers (Invitrogen) and then used with either T3 and T7 RNA polym-
erase for the single-stranded sense or antisense RNA synthesis using the
MEGAscript high yield transcription kit (Ambion Inc., Austin, TX).
Large quantities of dsRNA were prepared as previously described (47).
Soakingwith dsRNAwas performed onO. volvulus L3 as described (46),
with modifications. Briefly, cryopreserved L3 were thawed and washed
5with culturemedium (1:1 NCTC 135 and Iscove’s modified Dulbec-
co’s media, plus 100 units/ml penicillin, 100 g/ml streptomycin, and 2
mM L-glutamine) before their transfer to 96-well plates (5–15 larvae per
well in 50 l). Sterile dsRNA in culture medium was added in 50 l at a
final concentration of 0.5 mg/ml, and the larvae were cultured at 37 °C
in a humidified 5% CO2 incubator. After 20 h, 50 l of culture medium
was removed and 1.5 105 normal human peripheral blood mononu-
clear cells in 100 l of complete medium (culture medium plus heat-
inactivated fetal calf serum, final 10%) were added to the culture as
previously described (10). Uptake of dsRNA into the parasite was exam-
ined using fluorescent-labeled CyTM3-dsRNA as previously described
(46). The molting phenotype and morphology was observed under dis-
secting microscope every 24 h until the seventh day when the experi-
mentwas terminated.On day 7 larval viability was assessed visually after
the uptake of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazo-
lium bromide, Sigma) and its reduction into the blue formazan deriva-
tive (48), as described previously (49). Briefly, after incubation for 18 h at
37 °C, 5% CO2, in 100 l of 0.1%MTT, larval viability was scored as live
when larvae stained blue uniformly along their entire length and dead
when they remained unstained.Ov-spi dsRNA (targeting bothOv-spi-1
and Ov-spi-2 transcripts) was used as the test RNAi treatment, with
negative controls being either culture medium containing RNA storage
buffer or dsRNA of an unrelated Plasmodium falciparum gene Pf-eba-
140 (position 2914 to 3396; accession number MAL13P1.60), and a
positive control corresponding to the cathepsin L ofO. volvulus,Ov-cpl
(position 219–984, accession number U71150), which has been shown
to inhibit molting of L3 (46). Each RNAi experiment was repeated at
least twice. The averagemolting of the control group is considered 100%
of molting in each experiment, and the relative reduced molting rate of
each experimental group is calculated accordingly. The results shown
are the mean percent inhibition of molting in each experimental group,
and the standard deviation reflects the variation between experiments.
Loss of Ov-spi-1 and -2 Transcripts and Native Ov-SPI Proteins fol-
lowing RNAi—Loss of Ov-spi-1 and Ov-spi-2 transcripts following
RNAi treatment were examined by quantitative real-time PCR, where
Ov-spi dsRNA treatment was expected to affect transcript levels of both
Ov-spi-1 andOv-spi-2 due to their high degree of identity. Primers used
were specific for either Ov-spi-1 (OvSPI1F2; 5-AACTGCATTTGTG-
GTACTT-3 and OvSPI1R2; as above), which were designed outside
Multiple Roles of Ov-SPI-1 in O. volvulus Development
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FIGURE 1. A, a comparison of the filarial SPI sequences. The schematic shows a representation of the filarial SPI-1s. The boxes show a schematic representation of the three different
regions: signal peptide (SP, yellow); mature inhibitory (TIL, blue) domain; and C-terminal region (white), found in the protein sequences. The length of the boxes is proportional to the
length of the domains in the corresponding protein group. The conserved positions of intronswithin the filarial SPI-1 are shownwith empty inverted triangles. The position of the first
intron in Ls-spi-1 is shifted 3 bp forward relative to the other filarial SPIs. The positions of the ten conserved cysteines (C, red), and the disulfide bonds they are predicted to form are
shownwith connectingbars. The closed inverted triangle shows thepositionof thepredicted inhibitory loop foundbetween fifth and sixth cysteines. Theopen circlewithabar indicates
the position of the 10-bp deletion inOv-spi-2, which causes a shift in-frame and thus truncates the predicted SPI-2 protein by removing 11 aa of the C-terminal region. The hexagons
show the twopotentialN-glycosylation sites found inOv-SPI-1with the second site also being conserved in Bm-SPI-1. B, comparison of the reactive site regions of nematode TILs. The
figure shows an alignment of the inhibitory loop (residue P3 to P1) residing between the fifth and sixth cysteines of the nematode TIL domains analyzed in this study. The residues
are colored according to their biochemical properties and the sequences grouped according to their known or predicted substrate specificities. The groups are as follows: VIIa, factor
VIIa; Xa, factor Xa; T, trypsin; C/E, chymotrypsin/elastase; and “?” is unknown. The underline indicates there is a gap in the sequence, and the asterisk indicates there are several
additional residues before the sixth cysteine. C, Bayesian phylogenetic analysis of nematode SPI domains. The tree shown in this figure is a consensus built from 9,750 trees saved
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the target domain of theOv-spi dsRNA, orOv-spi-2 (OvSPI1F; as above
and OvSPI2R; as above). Ov-calponin (Ov-9M; accession U01099), was
amplified as a control housekeeping gene (Ov9F; 5-GACGTGAGAC-
GACGAA-3 and Ov9R; 5-GCACCGAATCCAGTCA-3). 200
RNAi soaked L3 larvae were collected after 20 h of RNAi treatment,
RNA extracted as previously described (14), and first strand cDNA was
generated using the SuperScript™ III first strand cDNA synthesis kit
(Invitrogen) and priming with oligo(dT)20. The specific cDNA frag-
ments were then amplified, and the copy number quantified by real-
time PCR using QuantiTechTM SYBR Green PCR kit (Qiagen) and the
ABI Prism 7700 Sequence Detection System. The PCR conditions used
were 50 °C for 2min, 95 °C for 15min, followed by 43 cycles of 94 °C for
30 s, 52 °C for 30 s, and 72 °C for 45 s. To determine the copy number of
each transcript within the different cDNA preparations, standard
curves for Ov-spi-1, Ov-spi-2, and Ov-calponin were drawn based on
quantitative PCR using known amounts of template DNA in a range of
10–106 copies. The relative content of the transcript corresponding to
Ov-spi-1 or Ov-spi-2 is expressed by normalizing to Ov-calponin and
represents the ratio betweenOv-spi copy numbers relative toOv-calpo-
nin. Normalized expression in the control sample was set to 1.0, and the
values for Ov-spi-1 and Ov-spi-2 in the RNAi-treated samples were
calculated.
The effect of RNAi on the expression of theOv-SPI-1/SPI-2 proteins
in Ov-spi RNAi-treated O. volvulus was examined by immunoelectron
microscopy.Worms were collected on day 5 and fixed for immunoelec-
tronmicroscopy analysis as previously described (30, 45). Thin sections
of control worms and Ov-spi dsRNA-treated worms were stained with
antibodies raised against rOv-SPI-1 as described above. The antibodies
used to localize Ov-CPZ and Ov-CPL proteins in the Ov-spi dsRNA-
treated larvae were already described (46).
Statistical Analysis—Comparison between the groups in RNA inter-
ference experiments were analyzed using the two-tailed non-paramet-
ric Mann-Whitney U test. A p value of  0.05 was considered statisti-
cally significant.
RESULTS
Identification of the Filarial Serine Protease Inhibitor Genes—The
cDNAs of the filarial spi genes encode open reading frames of 89–118
amino acids, with predictedmolecularmasses ranging from 9 to 13 kDa.
All sequences contain a predicted N-terminal signal peptide. The pre-
dicted size of the mature SPI proteins range from 68–97 aa and 7.5–11
kDa. Ov-SPI-1 contains two putative N-linked glycosylation sites near
its C terminus after the inhibitory domain (aa 105–107 and 115–117; see
Fig. 1A). Bm-SPI-1 contains one potentialN-linked glycosylation site in
its C terminus (aa 93–95; Fig. 1A). When the Ov-SPI-1 sequence was
searched against the O. volvulus EST dataset a second closely related
sequence was identified, Ov-spi-2, which has a 10-bp deletion in the
C-terminal region, relative to Ov-spi-1. This results in a frameshift
removing 11 amino acids of the C terminus of theOv-SPI-2 protein (Fig.
1A). Ov-SPI-1 exhibits 99% identity with Ov-SPI-2 over the first 104
amino acid residues, followed by a sequence with no identity (14 aa
Ov-SPI-1, 2 aaOv-SPI-2) due to the 11-aa deletion in the C terminus of
Ov-SPI-2. The Bm-SPI-1 and Di-SPI-1 sequences are 57.1% and 68.1%
identical toOv-SPI-1, respectively. Ls-SPI-1 has only 33.8–40.9% iden-
tity with the other SPI family members. No putative N-linked glycosy-
lation sites were identified in Ov-SPI-2, Ls-SPI-1, or Di-SPI-1.
The fully sequenced genomic fragments containing the predicted
exons of Ov-spi-1, Ov-spi-2, Bm-spi-1, Di-spi-1, and Ls-spi-1 have been
deposited in GenBankTM (accession numbers: DQ013160, DQ013161,
DQ013155, DQ013159, and DQ013158, respectively). Analysis of the
fragments establishes thatOv-spi-1 andOv-spi-2 are not splice variants,
because the deletion does not occur at either of the verified intron
splicing sites. Although the sequence of the second intron of Ov-spi-1
and Ov-spi-2 show a high level of sequence conservation, four single
base changes and a 2-bp insertion were found in Ov-spi-2 relative to
Ov-spi-1 genomic sequence. In addition, the 3-untranslated region of
Ov-spi-2 has four base changes, two single base insertions, and a single
16-bp insertion relative toOv-spi-1. The two intron positions in the two
Ov-spi sequences are also conserved inBm-spi-1 andDi-spi-1, but not in
Ls-spi-1 (Fig. 1A).
Searches of the GenBankTM non-redundant and EST datasets
revealed that TIL-like domains could be found in predicted proteins
from themajority of nematode EST datasets as well as some arthropods
and vertebrates. Within the nematode sequences the filarial SPIs
showed the highest sequence similarity to the A. suum chymotrypsin
and elastase inhibitors (IC/E) and the Anisakis simplex serine protease
inhibitors (41–68% sequence similarity). Comparisons of the filarial SPI
sequences to the predicted proteins of the C. elegans genome showed
that Ov-SPI-1 and -2, Bm-SPI-1, and Di-SPI-1 showed the highest sim-
ilarity to R10H1.4 (47–59%), whereas Ls-SPI-1 was most similar to
C25E10.10 (52%).
The reactive site of SPIs is designated as P3-P2-P1/P1-P2 (50). Fig. 1B
shows an alignment of the reactive site loops of the filarial SPIs (Ov-
SPI-1 and -2 amino acid sequence, CALRC;Bm-SPI-1, CFLIC; Ls-SPI-1,
CYKKC; and Di-SPI-1, CTLIC) and other nematode SPIs with charac-
terized protease specificities (ascarid, hookworm, and tricurid SPIs:
ASCSU_IC/E-1, CPLMC; ASCSU_IC/E2–5, CALMC; ASCSU_ATI,
CTREC; ANSSI_SPI_1, CPAMC; ANSSI_SPI-2/3, CATIC; ANC-
CA_APc2 and ANCCA_AP3, CLVRVC; ANCCA_AP4, CILRVC;
ANCCA_AP5, CRSRGC; ANCCA_AP6, CRSFSC; TRISU_TCI1,
CTRQC; and TRISU_CEI1, CTMQC) (51, 52). Two hookworm and ten
C. elegans SPIs with unknown protease specificities have also been
included in the alignment. The sequences have been grouped according
to the characteristics of the amino acid residues found in the P1/P1
positions, and their potential target enzymes were deduced from the
sequences found in the characterized inhibitors. In three of the filarial
inhibitors and the Ascaris IC/E inhibitors the amino acid leucine occu-
pies the critical P1 position. The P1 site displays more variation with
aliphatic amino acids inAscarid SPIs and two of the filarial SPIs (methi-
onine in the Ascaris C/E inhibitors and Anisakis SPI-1, isoleucine in
Anisakis SPI-2/3, Bm-SPI-1, andDi-SPI-1), and charged residues in the
filarial Ls-SPI-1, and Ov-SPI-1 and -2 (lysine or arginine). The reactive
site sequenceof theA. suum trypsin inhibitor (ATI)differswith thecharged
amino acids arginine and glutamic acid occupying the P1 and P1 reactive
sites, respectively (Fig. 1B) (53, 54). Based on the composition of their reac-
tive sites we speculated that the Onchocerca SPI-1 and -2 target a chymo-
trypsin/elastase-like protease. Using these criteria we also predict the
majority of theC. elegans inhibitors included in our study (eight out of ten)
will have similar target protease preferences. The remaining C. elegans
inhibitors CAEEL_R10H1_4 andCAEEL_F32D8_3 have arginine or lysine
in the P1 position indicating that they may inhibit trypsin-like proteases.
during Bayesian analysis of the SPI protein alignment, rooted using the two T. suis sequences. Posterior probability values for each node0.65 are shown in black. The bootstrap
values (65) of a distance analysis (neighbor joining; 10,000 replicates) of the same alignment are shown in red. The name includes a five-letter species identifier and the SPI gene
name. Based on the results of the phylogenetic analysis a subset of the TIL domains have been divided into three groups: Ia, C. elegans T06E6.10 and hookworm TILs; Ib, seven C.
elegans TILs; and II, C. elegans R10H1.4, ascarid, and filarial TILs.
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Phylogenetic Analysis of the Nematode Serine Protease Inhibitor Pro-
tein Sequences—Phylogenetic analysis of the nematode TIL domains
from C. elegans, ascarid, and filarial SPIs, using the Bayesian and neigh-
bor joining analysis, indicates that the filarial SPI sequences are part of a
large clade, which includes the previously isolated ascarid TILs from A.
suum and A. simplex, as well as the C. elegans open reading frame
R10H1.4 (Fig. 1C). All nodes yielding posterior probability value of
0.65 or bootstrap values of65 are indicated. Three supported groups
have been designated Ia, Ib, and II. Group I contains most of the SPI
sequences derived from Clade V nematodes (39). Group Ia consists of
the hookworm factors Xa and VIIa inhibitors andC. elegansT06E06.10,
whereas the poorly supported group Ib (probability value of 0.65) con-
sists of seven C. elegans sequences. Group II consists of the C. elegans
R10H1.4, ascarid, anisakid, and filarial SPIs. The A. simplex andmost of
the filarial SPIs form their own subgroups. The overall low sequence
similarity (33.8–40.9%) of Ls-SPI-1 to the other filarial SPIs, its unique
intronic splice sites, and its exclusion from the filarial clade indicate that
it may not be part of the same TIL subgroup as the other filarial
sequences.
Homology-based Modeling of Ov-SPI-1 and Bm-SPI-1—The homol-
ogy-basedmodeling ofOv-SPI-1,Bm-SPI-1, andDi-SPI-1whenmerged
with the x-ray crystal structure of porcine elastase (PDB code 1EAI),
showed mutual penetration characteristics as observed in the A. suum
chymotrypsin/elastase inhibitor bound crystal structure. The P1 resi-
due, Leu-31, of the inhibitor penetrates into the S1 substrate specificity
pocket, and R217A of elastase penetrates through a pore formed by the
A. suum IC/E-1 inhibitor (40). The later penetration is a unique feature
and has not been reported for any other protein inhibitor-protease com-
plex. Although the residues in the P1 site vary in all three inhibitors
studied here, one of the key residues, Leu-31 (P1), reported as indicative
of an inhibitor of both chymotrypsin and elastase (52), is conserved inA.
suum IC/E and in the three filarial inhibitors studied. In all of the mod-
eled filarial structures Leu-31 can interact with the Val-216 of elastase
similarly to that published for theA. suum IC/E interactionwith elastase
(40). Ls-SPI-1, which has lysine instead of leucine at this position, is not
predicted to have thismutual penetration characteristic. The residues in
the P2 site, Pro-30 and Ala-30 in A. suum IC/E-1 andOv-SPI-1, respec-
tively, do not participate in any specific interactions with the residues of
elastase; however, phenylalanine in the P2 position in Bm-SPI-1 is pre-
dicted to interact with Val-99 in elastase. The major interactions
appeared to be hydrophobic. The amino acid residues in the P1 site at
position 32, which varied in all these three structures, did not appear to
have any overall effect in terms of interactions with elastase. We note
that of course the nematode (and possibly host) enzymes targeted by
these inhibitors will differ in sequence and fine-scale structure to the
porcine elastase used in modeling and that there may be additional
significant interactions with their true substrates.
Inhibitory Activity of rOv-SPI-1—The inhibitory activity of histidine-
tagged rOv-SPI-1 was examined by testing its ability to inhibit a variety
of serine proteases (trypsin, chymotrypsin, elastase, and cathepsin G).
Protease activity and specific inhibition was examined bymeasuring the
hydrolysis of specific fluorogenic AMC substrates over time. The rOv-
SPI-1 inhibitor inhibited the enzymatic activity of all serine proteases
screened in a dose-dependent manner (Fig. 2), specifically inhibiting
elastase to the greatest extent (92.4% at the highest amount of rOv-SPI-
1), followed by chymotrypsin (60.2%) and cathepsin G (57.3%), and to a
lesser extent trypsin (30.5%). The chemical inhibitors of serine proteases
inhibited almost completely (85–100%) all of the serine proteases
screened (data not shown). The specific serine protease inhibitory activ-
ity of rOv-SPI-1 was confirmed using a reverse zymography technique,
where the inhibitory activity of rOv-SPI-1 was detected as a single band
with an apparent molecular mass of 16 kDa (including 4 kDa for the
histidine tag extension) on stained substrate gel slices, that was resistant
to both elastase and chymotrypsin, but not trypsin activity (data not
shown).
Profile of Ov-spi-1 and Ov-spi-2 Expression throughout the Parasites
Life Cycle—Primers were designed to specifically amplify either Ov-
spi-1 or Ov-spi-2 from different developmental stages of O. volvulus.
PCR on O. volvulus stage-specific cDNA libraries indicated that the
transcripts of Ov-spi-1 are present in all life-cycle stages from microfi-
lariae to adults, with expression increasing during molting of L3 (mL3)
and in adult stages (Fig. 3). Ov-spi-2, however, was only found to be
transcribed in L2 and the post-human-infection parasite stages (mL3 to
adult) (Fig. 3). Previous analysis of theO. volvulus EST datasets (13, 55)
indicates thatOv-spi-1 andOv-spi-2may be up-regulated in mL3 (clus-
ters OVC00017, OVC03875, and OVC08442; 41 ESTs, 33 of which are
derived from themL3 dataset), and they represent the third most abun-
dant transcript in themL3 dataset (12). Because of the subtle differences
between theOv-spi-1 andOv-spi-2 transcripts the EST clustering algo-
rithms have not successfully differentiated between them. However, by
specifically searching theO. volvulus ESTdatasets we identified 21 ESTs
encodingOv-spi-1, 11 ESTs encodingOv-spi-2, and 9 that could not be
assigned to either gene because of lack of sequence covering the 10-bp
deletion site. In both cases the majority of ESTs were isolated from the
mL3 dataset indicating that both are highly expressed at that stage.
Immunolocalization of Native Ov-SPI Proteins in O. volvulus—Spe-
cific antibodies raised against rOv-SPI-1 (anti-Ov-SPI-1), which has 99%
identity toOv-SPI-2 over their first 104 amino acids, were used to detect
their corresponding native proteins in the parasite. The endogenous
protein corresponding to Ov-SPI-1 and -2 was localized by immuno-
electronmicroscopy on sections taken from different life-cycle stages of
O. volvulus. In L3, Ov-SPI-1 and -2 were present within the body chan-
nels (Fig. 4, A and B), within the multivesicular bodies (Fig. 4B), and in
the basal layer of the cuticle (Fig. 5B). Intense labeling was also seen in
the basal layer of the cuticle of mL3 (Fig. 4,C andD). After separation of
the L3 and L4 cuticles, theOv-SPI-1 and -2 proteins were present in the
basal layer of both the old L3 cuticle and the new L4 cuticle (Fig. 4D).
Interestingly, intense labeling was also observed in the processed mate-
FIGURE 2. Serine protease inhibitory activity of rOv-SPI-1 is concentration depend-
ent. Different amounts of rOv-SPI-1 were preincubated with 0.5 g of serine proteases
(elastase, chymotrypsin, cathepsin G, and trypsin) before the addition of specific fluoro-
metric substrates, and the residual protease activity was measured. Inhibitory activity is
expressed as a percentage, defined as the ratio of decreased activity relative to the no
inhibitor control. All assays were performed in triplicate and values are the means of
three independent experiments.
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rial, which appears between the L3 and L4 cuticles during molting in
control larvae (Fig. 5D, panel b). No labeling was observed in the glan-
dular esophagus. In addition, the antibodies recognized protein in egg-
shells surrounding developing embryos within the uterus of adult
female worms (Fig. 4E) and strongly labeled sperm within the testis of
adult male worms (Fig. 4F). Pre-immune sera did not cross-react with
any proteins in the sections of life-cycle stages of O. volvulus (data not
shown).
RNAi of Ov-spi in O. volvulus L3 Results in a Reduction in Larval
Molting and Viability Due to a Specific Depletion of Ov-spi-1 and -2
Transcripts andNative Proteins—Todetermine the possible function(s)
of Ov-SPI-1 and Ov-SPI-2 during molting of O. volvulus, RNAi was
carried out to selectively interfere withOv-spi-1 and -2 gene expression
using dsRNA corresponding to an identical coding region of both pro-
teins (bp 67–362). Both molting and viability were affected in Ov-spi
dsRNA-treatedO. volvulus L3 (Fig. 5,A andB, respectively). In compar-
ison to 19–33% molting in the normal culture media control groups,
treatment with Ov-spi dsRNA resulted in a 84.2% inhibition of ecdysis,
whichwas statistically significant (Mann-WhitneyU test, p 0.001). L3
cultured in the presence of Pf-eba-140 dsRNA showed some reduction
in molting (24.7%) relative to the control. The molting of Ov-spi
dsRNA-treated L3s was significantly reduced in comparison to the Pf-
eba-140 dsRNA-treated L3s (p  0.008). Treatment with Ov-spi-1
dsRNA significantly affected the viability of L3, which had notmolted by
day 7 (Fig. 5B), where treatment resulted in a 39.4% death of L3 relative
to the control (p  0.032). Pf-eba-140 dsRNA treatment of L3 did not
affect their viability (2.2% killing similar to that of control group with no
dsRNA). The viability of Ov-spi-1 dsRNA-treated L3s was significantly
reduced in comparison to the Pf-eba-140 dsRNA-treated (p 0.016).
Analysis of specific gene transcript levels following RNAi treatment
showed that both Ov-spi-1 and Ov-spi-2 transcripts in Ov-spi dsRNA-
treated L3 were severely diminished, 200-fold, when compared with
RNAi treatment with either the negative control dsRNA (Pf-eba-140),
or dsRNA corresponding to the O. volvulus cathepsin L (Ov-cpl) (Fig.
5C). Transcript levels in the medium control were comparable to those
in the negative control dsRNA (data not shown). Immunoelectron
microscopy demonstrated that the nativeOv-SPI-1/SPI-2 proteins were
highly reduced following Ov-spi dsRNA treatment (Fig. 5D). In normal
control molting larvae Ov-SPI-1/SPI-2 was localized to the cuticles of
both L3 and L4 (Fig. 5D, panels a and b), whereas in Ov-spi RNAi-
treated L3 the labeling of Ov-SPI-1/SPI-2 was almost absent (Fig. 5D,
panel c). Notably, larvae that did not successfully molt after Ov-spi
dsRNA treatment exhibited incomplete separation between the L3 and
L4 cuticles (Fig. 5D, panel c). Interestingly, in control larvae intense
labeling was also observed in the processed material, which appears
between the L3 and L4 cuticles during molting (Fig. 5D, panel b). The
labeling ofOv-SPI-1/SPI-2 in L3 andmL3 confirmed our previous local-
ization of the endogenous protein (Fig. 4), however, in addition the
preservation of material being degraded between the cuticles during
molting shows that the endogenous inhibitors are present during the
degradation of cuticular material during molting. The localization ofO.
volvulus cathepsin L- and Z-like proteases, known to have an essential
function during molting (46), were not affected by the Ov-spi dsRNA
treatment (Fig. 5D, panels d and e).
DISCUSSION
Parasite-derived protease inhibitors have been shown to play a variety
of roles in the survival of the parasite by inhibition of exogenous host
proteases (18, 20, 29). They are also believed to control endogenous
proteases involved in the development and reproduction of the parasite
(30). Here we describe the identification and characterization of a novel
family of low molecular weight serine protease inhibitors (SPIs), Ov-
SPI-1 and Ov-SPI-2, from the human parasitic nematode O. volvulus.
FIGURE 3. Transcription of Ov-spi-1 and Ov-spi-2 through the life cycle of the para-
site. PCR was performed on O. volvulus cDNA libraries of microfilariae (Mf), L2, L3, molt-
ing L3 (mL3), adult female (AF), and adult male (AM). Specific primers for Ov-spi-1, Ov-
spi-2, and-tubulin (Ov-tub-1) were used for specific gene amplification.-Tubulin is the
normalization control for all other lanes.
FIGURE 4. Immunolocalization of native Ov-SPI-1/SPI-2 in sections of different
developmental stages of O. volvulus. Thin sections of O .volvulus L3 (A and B), mL3 (C
and D), adult females (E), and adult males (F) were incubated with anti-Ov-SPI-1 mouse
antibodies, followedby incubationwith rabbit anti-mouse IgG, and then incubationwith
protein A coupled to 15-nm gold particles for ultrastructural localization of the native
Ov-SPI-1/SPI-2 proteins (bar represents 500nm). In L3, anti-Ov-SPI-1 antibodies intensely
labeled thebody channels (small arrowhead) (A andB) andmultivesicular bodies (B;mvb)
having a role in the early stageofmolting. InmL3, antibodies reactedwithproteins in the
basal layer of the cuticle (big arrowhead) (C and D), after cuticle separation labeling was
seen in the basal layer of both the old L3 (big arrowhead) and new L4 cuticles (arrow)
during both early and late stages of molting (C and D, respectively). In adult stages
antibodies reactedwith the eggshell (es) surrounding developing embryos (emb) within
the uterus of the adult female worms (E), and intensely labeled sperm (sp) within the
testis of adult male worms (F).
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Subsequent searching of other filarial EST datasets allowed us to iden-
tify three other members of this family from B. malayi, D. immitis, and
L. sigmodontis (Bm-SPI-1, Di-SPI-1, and Ls-SPI-1, respectively). This
group of lowmolecular weight serine protease inhibitors was first iden-
tified in A. suum and A. lumbricoides (16, 18, 51, 54) where they are
believed to protect the nematode from intestinal serine proteases.
Members of the family have been identified in other parasitic nema-
todes, including the ascaridid A. simplex (20, 52, 56), the strongylid
hookworms A. caninum and A. ceylanicum (17, 23, 25), and the whip-
worm T. suis (21, 57). These SPIs are also believed to be involved in
controlling exogenous host proteases in these nematodes. The inhibi-
tory portions of these proteins have been designatedTIL domains (tryp-
sin inhibitor-like) within pFam. The completed C. elegans genome con-
tains nineteen different genes with TIL domains (36), none of which
have been purposely characterized functionally in regard to their spe-
cific roles during development. Regardless, they presumably play a vari-
ety of roles in the biology of this free-living nematode. There were no
reported RNAi phenotypes associated with any of these genes in the
recently published genome-wide screens (www.wormbase.org). Mem-
bers of this family have been identified in arthropods such as the hon-
eybee Apis mellifera (58, 59), Drosophila melanogaster (60), gall wasps
(61), and scorpions (62). Their functions in arthropods have not yet
been fully elucidated, although they are reported to be involved in deter-
mining lifespan or are components of insect venoms. TIL domain pro-
teins have also been isolated from frogs, where they are believed to exert
anti-microbial properties (63, 64). In mammals TILs have been identi-
fied in a variety of proteins such as vonWillebrand factor or zonadhesin,
which have roles in blood clotting and sperm gamete recognition, or
adhesion (65, 66). The mammalian TILs have always been found in the
context of large multidomain proteins (see entry for PF01826). This
FIGURE 5. RNAi treatment ofO. volvulus L3withOv-spi dsRNA results in an inhibition ofmolting and viability due toOv-spi-1 and -2 gene specific knock-down.O. volvulus
L3 were soaked in dsRNA at a final concentration of 0.5 mg/ml as described under “Experimental Procedures.” Larvae were cultured in the presence of dsRNA for 20 h at 37 °C in
humidified 5% CO2, after which 1.5  10
5 normal human peripheral blood mononuclear cells were added and L3 were cultured for an additional 6 days. A, Ov-spi RNAi led to a
significant inhibition ofmoltingwhen comparedwith the Pf-eba-140dsRNA control group. The data are presented as percent inhibition relative to the normalmolting control group,
where the average ofmolting is considered 100%ofmolting, and the relative reducedmolting rate of the two experimental groups is calculated accordingly. B,Ov-spidsRNA-treated
L3, which had not molted by day 7 showed significantly reduced viability. C, quantitative real-time PCR was carried out on total RNA isolated from200 control or RNAi-treated O.
volvulus L3 after 20-h incubation withmedium alone or dsRNA. PCR primers were specific toOv-spi-1,Ov-spi-2, or to the control geneOv-calponin.Ov-spi expression was normalized
toOv-calponin expression and normalized expression in the control groupwas set to 1.0. BothOv-spi-1 andOv-spi-2 RNAwere depleted inOv-spi dsRNA-treated L3s compared with
Pf-eba-140 or Ov-cpl dsRNA-treated L3s. D, immunoelectron microscopy was performed on control (a and b) and Ov-spi RNAi-treated (c) L3 collected on day 5 as described under
“Experimental Procedures.” The native Ov-SPI-1/SPI-2 proteins were localized to the new L4 cuticle, in-between the old and new cuticles in the control larvae (a and b), but their
expression was almost completely reduced in the Ov-spi RNAi-treated larvae (c). The presence and localization of Ov-CPZ-1 (d) and Ov-CPL-1 (e) in the Ov-spi RNAi-treated L3s was
similar as in normal mL3. The regions where the cuticles of L4 and L3 separate are marked by an arrowhead and an arrow, respectively. Each bar represents 500 nm.
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contrasts amphibians, nematodes, and arthropods, where multiple
examples of proteins just containing an N-terminal signal peptide and a
single TIL domain have been identified.
We initially identified the O. volvulus SPIs through the analysis of a
molting L3 EST dataset and subsequent PCR analysis of stage-specific
cDNA libraries, which indicate that these genes are highly expressed in
the molting larvae and adult datasets. Sequence analysis of the two
Ov-spi cDNAs showed that they were closely related with only a 10-bp
deletion in the C-terminal region of the open reading frame differenti-
ating the coding sequences. Cloning and sequencing of genomic frag-
ments indicates thatOv-spi-1 andOv-spi-2 are separate genes or alleles
of the same gene and not splice variants. If theOv-spi-1 andOv-spi-2 are
separate genes, the high level of conservation in the intron sequences
indicates that they are derived from a recent gene duplication.
Comparison of the results of the phylogenetic analysis (Fig. 1C) and
the alignment of the nematode SPI reactive site loops (Fig. 1B) show that
while clear relationships between the nematode SPI genes can be
deduced, highly supported groups show heterogeneity in the predicted
protease target specificity. This indicates that substrate specificity has
not evolved in amonophyletic fashion but has remained highly dynamic
perhaps in response to rapidly evolving endogenous biological pro-
cesses or variable exogenous host targets (immune system or digestive
enzymes). Both sequence analysis and predictive modeling indicated
that the Ov-SPI-1 and Ov-SPI-2 may target chymotrypsin/elastase-like
proteases. Enzyme assays of bacterially expressed recombinant
Ov-SPI-1 confirmed that these proteins are capable of inhibiting a vari-
ety of serine proteases particularly elastase, chymotrypsin, and cathep-
sin G.
The potential endogenous function of the Ov-SPI proteins was
explored indirectly using immunolocalization of the proteins during the
development of the parasite. In the context of molting of L3 to L4, the
native proteins were localized in L3 to the body channels, the basal layer
of the cuticle, and themultivesicular bodies. The presence of the protein
in the body channels of L3s suggests that it is being transported to the
cuticle (67), whereas localization in themultivesicular bodies of the L3 is
an important observation, because these vesicles appear to contain pro-
teins exported to the cuticle during molting.5 The Ov-SPI proteins are
present in the basal layer of the cuticle of L3, the shed cuticle of L3, and
the newly formed cuticle of L4. They were also localized to the material
being processed and/or degraded between the cuticles during molting,
suggesting that they could be involved in the inhibition of and/or regu-
lation of one or more serine proteases that are essential for the process-
ing/degradation of such cuticular proteins. Proteases involved in molt-
ing are thought to be active in areas beneath the basal layer of the old
cuticle (2, 10). A cystatin-like cysteine protease inhibitor,Ov-CPI-2, has
been found to have a similar localization profile as the Ov-SPIs. It has
been suggested thatOv-CPI-2 controls the activity of cysteine proteases
essential formolting of L3 to L4 such asOv-CPZ-1 orOv-CPL-1 (10, 14,
30, 46).
Although the endogenous target enzyme of Ov-SPI-1 is yet to be
identified, a number of nematode serine proteases have been identified
(20, 68–71). Serine proteases have been implicated indirectly in the
molting processes ofC. elegans (72–74). A family of subtilisin-like serine
proteases, including furin and blisterase, has been identified in filariae
and shown to be involve in processing of cuticular proteins (75, 76).
Interestingly,Ov-blisterase localizes to the same regions of the cuticle in
molting O. volvulus L3s as the Ov-SPI proteins,6 suggesting that this
endogenous enzyme could be a potential target of Ov-SPI-1 and/or
Ov-SPI-2. In C. elegans, blisterase is encoded by the bli-4 gene, which
gives rise to at least nine protein isoforms by alternative splicing (72),
and these enzymes are involved in the processing of hormones and
structural components required for molting and the genesis of the new
cuticle (72, 73). More recently it has been shown that bli-4 is essential
formolting inC. elegans using RNAi (77).Moreover, elastase-like serine
protease activity has been detected in the secretions of Onchocerca lie-
nalis L3s (78). Interestingly, serine proteases have been shown to be
involved in the control of molting and larval development in insects
(79–84). In addition, Kunitz-type serine protease inhibitors are constit-
uents of the molting fluid inD. melanogasterwhere they are believed to
control enzymes involved in tissue remodeling (85). Recently, using
genome wide RNAi screening, it has been shown that serine protease
inhibitors containing the Kunitz/bovine pancreatic trypsin inhibitor
domains are also essential formolting inC. elegans (77).We suggest that
the Ov-SPIs might act in a similar manner regulating the activity of a
serine protease(s) involved in nematode molting. In addition to their
potential role inmolting, it is possible that theOv-SPIs are secreted onto
the surface of the nematodes cuticle or into the immediate vicinity to
prevent autodigestion of its cuticle by its own secretions.
We directly addressed the function of the Ov-SPIs in molting by
RNAi targeting of the Ov-spi-1 and Ov-spi-2 transcripts. When com-
pared with the untreated control or the Pf-eba-140 control (dsRNA
treatment control) the Ov-spi RNAi treatment of L3s significantly
inhibitedmolting. The treated L3s failed to shed their cuticles, displayed
aberrant morphology, and reduced viability. These phenotypic differ-
ences were correlated with a loss of both Ov-spi-1 and Ov-spi-2 tran-
scripts, and a specific reduction in native Ov-SPI-1/SPI-2 proteins. As
described previously by Lustigman et al. (46)we noted somenonspecific
toxic effect of unrelated dsRNAonmolting. It is unclear what themech-
anism for this nonspecific effect is, however, reverse transcription-PCR
of the targeted transcripts does not indicate an indirect knockdown in
their transcription. Also the protein expression of two previously char-
acterized cysteine proteases involved in molting (Ov-CPL-1 and Ov-
CPZ-1) (46) was unaffected. Off-target effects have been reported to
occur in RNAi of mammalian cells (86, 87), and it possible that the
AT-rich P. falciparum gene fragment is acting on other AT-rich tran-
scripts found in O. volvulus (88). Whereas we have not specifically
explored the mechanism of Ov-spi RNAi lethality, it is probable that it
results from the unsuccessful emergence of the L4 from the old L3
cuticle.
An interesting finding in this study was the overall similarity between
the RNAi phenotypes ofOv-spi,Ov-cpl-1, andOv-cpz-1 (46) in molting
L3s. All display a similar failure in the separation of L3 and L4 cuticles.
The knockdown ofOv-spi does not affect the transcription of the other
two genes or the localization of their native proteins. It seems likely the
Ov-SPIs regulate molting via inhibition of their unidentified endoge-
nous target enzyme, and this activity appears to be independent of the
presence of the cysteine proteasesOv-CPL-1 andOv-CPZ-1 in the same
locations. It is possible that these proteins act in independent pathways
that subsequently converge when the cuticles begin separation. Alter-
natively, theOv-SPIs could be involved in controlling the maturation of
these cysteine proteases by a serine protease and while they are success-
fully targeted to the cuticle interfaces in its absence the cysteine pro-
teases may not be fully active and thus molting is inhibited.
The expression of the Ov-spi transcripts in the other lifecycle stages
of O. volvulus suggests they have functions outside of molting. The
native proteins were also immunolocalized to the eggshells surrounding
developing embryos within the uterus of adult female worms, and to
5 Y. Oksov, unpublished observation.
6 S. Lustigman and C. Poole, unpublished data.
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spermwithin the testis of adult male worms suggesting a role in embry-
ogenesis, microfilarial development, and spermatogenesis. Bm-spi-1 is
also expressed in a variety of lifecycle stages suggesting that these inhib-
itors may have similar multifunctional roles in the other filariae. The
A. suum chymotrypsin/elastase inhibitors have been localized to the
eggs, egg-shell-derived sheath of the L2 stages, and sperm, either
through specific antibodies or treatment with fluorescently labeled pro-
teases (89, 90). However, these studies did not address whether or not
the A. suum inhibitors were also inhibiting endogenous nematode pro-
teases participating in the tissue remodeling processes taking place in
the developing embryos. Although we do not know what functions the
Ov-SPIs have in nematode sperm, another TIL domain-containing
protein has been identified as a component of the seminal fluid of
D.melanogaster (60) suggestingTILsmight have conserved functions in
sperm biology. Serine proteases are known to be involved in embryonic
development (91) in a variety of organisms. In C. elegans, blisterases
have been shown to be involved in early development of the nematodes
as well as in cuticle formation (reviewed in Refs. 72–74). It is possible
that there are targets of the Ov-SPIs in the adults as well as the molting
larvae.
Moreover, it is possible that, like other previously characterized nem-
atode protease inhibitors, such as the cystatin family (29, 30) and the
serpin family of serine protease inhibitors (27, 28, 92), theOv-SPIs have
exogenous as well as endogenous functions during the lifecycle of the
parasite. This could involve the control of both host and parasite ecto-
proteases. Filarial cystatins have been shown to have immunomodula-
tory properties either through direct effects on immune cell activation
or by blocking antigen processing and presentation on class II major
histocompatibility complex (29, 93–98). Nippocystatin, a cysteine pro-
tease inhibitor from Nippostrongylus brasiliensis, was also shown to
inhibit antigen processing and modulate antigen-specific immune
responses to the parasite (99). Serine protease inhibitors belonging to
the serpin family, such as viral serpins (100–102), have also been impli-
cated in immunomodulation. A filarial serpin identified in B. malayi
(26) acts as a major T cell antigen (103), whereas a serpin from the
intestinal nematode Trichostrongylus vitrinus inhibits host serine pro-
teases (104). We are currently exploring the immunomodulatory prop-
erties of the Ov-SPIs and their ability to specifically inhibit proteases
released from activated neutrophils andmonocytes, such as elastase and
cathepsin G (reviewed in Refs. 105 and 106), which may be involved in
the control of inflammation (107, 108). Neutrophils have been found to
be important effector cells in the killing ofO. volvulus larvae (109, 110).
They are also involved in the pathology associated with nodule forma-
tion around adultOnchocercaworms (111), microfilaria-mediated ocu-
lar pathology (112, 113), and are involved in the immune responses
generated after anti-filarial treatment (114, 115). Control of proteases
released from these cells would be vital for establishment and long term
survival of the parasites within the host.
Indirect evidence of the involvement of the Ov-SPIs in immune reg-
ulation is that Ov-SPIs are antigenic and highly recognized by individ-
uals exposed to O. volvulus indicating exposure to the inhibitor,7 and
thus suggesting that they are released from the parasite during the early
stages of parasite establishment in the host. Interestingly, antibody
responses toOv-SPIs are higher in putatively immune individuals when
compared with age-matched infected individuals, and the responses are
up-regulated with age in chronically infected individuals7 suggesting a
role in protective immunity. Ov-SPI-1 is one of the vaccine candidates
against O. volvulus.
In conclusion, we have identified a novel filarial serine protease inhib-
itor family with potential multifunctional roles in the development of
the parasite, including molting, establishment in the final host, embry-
ogenesis, and reproduction. Future work will focus on identifying the
one or more potential target enzymes for the filarial serine protease
inhibitors, including both endogenous parasite and exogenous host ser-
ine proteases. Identification of their target proteases may be important
in the identification of potential targets for drug and vaccine develop-
ment as well as providing further information on the biology of molting
and adult reproductive processes in nematodes.
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